AIMS Social Equity Entheogenic Care Partnership

The Advanced Integrative Medical Science (AIMS) Institute in Seattle is a multi-specialty teaching clinic and research institute founded in 2018 offering cutting edge care in oncology, psychiatry, neurology, rehabilitation, pain, and palliative care. We provide coordinated, team-based care by licensed and board-certified allopathic medical and psychiatric specialists, specialized naturopathic physicians, psychotherapists, advanced practice and registered nurses, a social worker, and targeted health educators, with the majority of care covered by insurance, including Medicare. Additionally incorporated are novel ‘advanced’ approaches, such as entheogen-assisted psychotherapy using ketamine and hopefully soon psilocybin, medical cannabis education, sympathetic ganglion blocks, and advanced intravenous therapies which are generally considered experimental and uncovered by insurance. AIMS Institute works with our partners and the U.S. FDA and DEA towards conducting the first human study of ayahuasca tea therapy in the U.S. and is petitioning the DOJ/DEA in Court for access to psilocybin under the Right-to-Try law. AIMS Institute conducts IRB-approved prospective clinical outcomes studies to evaluate the safety and effectiveness of their therapy programs.

We are excited to improve the reach of our patient care and research mission by partnering with the Social Equity Entheogenic Care Fund.

Beyond Tribalism: Dr. Leanna Standish, Awake launch event, Nov 21, 2021

AIMS vs. DEA and AIMS Entheogenic Social Equity Care Fund

Click here to learn how you can donate to or apply for financial aid with the AIMS and Awake.net partnership.

Latest Blog Posts

AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

LJ STANDISH AND DAVID JAMES Dr. Standish and her team can help improve brain function, improve memory and slow cognitive decline in Alzheimer’s disease.  Please make an appointment to start.  Call 206-420-1321.  Scientific Rationale A protocol incorporating low-dose lithium orotate, Lion’s Mane mushroom extract, NADH, transcranial magnetic stimulation (TMS), and blood sugar regulation counseling is scientifically rational for treating cognitive decline based on mechanistic, preclinical, and emerging human studies. Low-Dose Lithium Orotate (5 mg/day) Recent brain tissue studies link low brain lithium to the onset and progression of Alzheimer’s disease, with deficiency accelerating synaptic loss and cognitive decline. Low-dose lithium orotate has ...

Read More
One Doctor’s Campaign to Let the Dying Take Psychedelics

One Doctor’s Campaign to Let the Dying Take Psychedelics

Psilocybin mushrooms on a dehydrator tray. Photographer: Jason Connolly/AFP/Getty Images By Charles Gorrivan September 3, 2025 at 3:00 AM PDT Corrected September 3, 2025 at 9:04 AM PDT Hi, it’s Charles in New York. When Brave New World author Aldous Huxley was on his deathbed in 1963, his wife injected him with two doses of LSD, the powerful psychedelic, as he slipped away. Was Huxley on to something? More on that in a moment, but first … Today’s must-reads RFK Jr. set new priorities for the CDC after firing its director. A big Danish pension fund bets that Novo Nordisk ...

Read More
Call Us Text Us
Skip to content